[go: up one dir, main page]

SI1115704T1 - Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse - Google Patents

Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse

Info

Publication number
SI1115704T1
SI1115704T1 SI9930391T SI9930391T SI1115704T1 SI 1115704 T1 SI1115704 T1 SI 1115704T1 SI 9930391 T SI9930391 T SI 9930391T SI 9930391 T SI9930391 T SI 9930391T SI 1115704 T1 SI1115704 T1 SI 1115704T1
Authority
SI
Slovenia
Prior art keywords
cyclin
inhibitory effect
new substituted
cdk complexes
various kinases
Prior art date
Application number
SI9930391T
Other languages
English (en)
Slovenian (sl)
Inventor
Rainer Walter
Wolfgang Grell
Armin Heckel
Frank Himmelsbach
Wolfgang Eberlein
Gerald Roth
Meel Jacobus C. A. Van
Norbert Redemann
Walter Spevak
Ulrike Tontsch-Grunt
R�DEN Thomas VON
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19844003A external-priority patent/DE19844003A1/de
Priority claimed from DE19937496A external-priority patent/DE19937496A1/de
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of SI1115704T1 publication Critical patent/SI1115704T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI9930391T 1998-09-25 1999-09-22 Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse SI1115704T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19844003A DE19844003A1 (de) 1998-09-25 1998-09-25 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE19937496A DE19937496A1 (de) 1999-08-07 1999-08-07 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
EP99947404A EP1115704B1 (fr) 1998-09-25 1999-09-22 Nouvelles indolinones substituees a effet inhibiteur sur differentes kinases et differents complexes cycline/cdk
PCT/EP1999/007040 WO2000018734A1 (fr) 1998-09-25 1999-09-22 Nouvelles indolinones substituees a effet inhibiteur sur differentes kinases et differents complexes cycline/cdk

Publications (1)

Publication Number Publication Date
SI1115704T1 true SI1115704T1 (sl) 2003-12-31

Family

ID=26049076

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930391T SI1115704T1 (sl) 1998-09-25 1999-09-22 Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse

Country Status (28)

Country Link
US (1) US6855710B2 (fr)
EP (1) EP1115704B1 (fr)
JP (1) JP2002525356A (fr)
KR (1) KR20010085841A (fr)
CN (1) CN1319090A (fr)
AT (1) ATE243195T1 (fr)
AU (1) AU763361B2 (fr)
BG (1) BG105327A (fr)
BR (1) BR9914065A (fr)
CA (1) CA2342622A1 (fr)
DE (1) DE59906030D1 (fr)
DK (1) DK1115704T3 (fr)
EA (1) EA200100320A1 (fr)
EE (1) EE200100184A (fr)
ES (1) ES2196860T3 (fr)
HR (1) HRP20010216A2 (fr)
HU (1) HUP0104973A3 (fr)
ID (1) ID27757A (fr)
IL (1) IL141622A0 (fr)
NO (1) NO20011477D0 (fr)
NZ (1) NZ510845A (fr)
PL (1) PL346898A1 (fr)
PT (1) PT1115704E (fr)
SI (1) SI1115704T1 (fr)
SK (1) SK4032001A3 (fr)
TR (1) TR200100854T2 (fr)
WO (1) WO2000018734A1 (fr)
YU (1) YU21301A (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
EP1430048A1 (fr) * 2001-09-27 2004-06-23 Allergan, Inc. L'utilisation de 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones en tant qu'inhibiteurs de kinases
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
HRP20040887A2 (en) 2002-03-26 2005-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7514468B2 (en) 2002-07-23 2009-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
PE20040701A1 (es) * 2002-07-23 2004-11-30 Boehringer Ingelheim Pharma Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
DE10233366A1 (de) * 2002-07-23 2004-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
US20040204458A1 (en) 2002-08-16 2004-10-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of Lck inhibitors for treatment of immunologic diseases
DE10237423A1 (de) 2002-08-16 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen
HRP20050185A2 (en) * 2002-08-29 2006-05-31 Boehringer Ingelheim Pharmaceuticals Inc. -3 (sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (ja) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド 疾患の治療のためのキナーゼ阻害剤
US20050043233A1 (en) 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
WO2005033330A2 (fr) * 2003-10-03 2005-04-14 Boehringer Ingelheim Pharmaceuticals, Inc. Sondes fluorescentes pour test de liaison d'inhibiteur de proteine kinase
CN1929834B (zh) 2004-03-11 2010-12-08 埃科特莱茵药品有限公司 吲哚-1-基乙酸衍生物
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20061155A1 (es) * 2004-12-24 2006-12-16 Boehringer Ingelheim Int Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas
DE602005015027D1 (de) 2004-12-27 2009-07-30 Boehringer Ingelheim Pharma Glucocorticoid-mimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und deren verwendung
MX2007012907A (es) 2005-04-28 2008-03-14 Boehringer Ingelheim Int Nuevos compuestos para el tratamiento de enfermedades inflamatorias.
KR20090097908A (ko) 2006-12-06 2009-09-16 베링거 인겔하임 인터내셔날 게엠베하 글루코코르티코이드 모사물, 이의 제조 방법, 이의 약제학적 조성물 및 용도
JP2010512407A (ja) * 2006-12-11 2010-04-22 ジェネンテック インコーポレイテッド 新生物を処置するための組成物および方法
CN101273991B (zh) * 2007-03-28 2010-05-26 广东同德药业有限公司 四氢吲哚酮/四氢吲唑酮/四氢咔唑衍生物及其盐在制备抗病毒药物中的应用
KR20100094497A (ko) * 2007-12-03 2010-08-26 베링거 인겔하임 인터내셔날 게엠베하 인돌리논 유도체의 제조 방법
PE20091445A1 (es) * 2007-12-03 2009-10-19 Boehringer Ingelheim Int Derivados de indolinona y procedimiento para su fabricacion
MX2010007950A (es) * 2008-01-25 2010-08-04 Boehringer Ingelheim Int Formas salinas de un derivado de 6-fluoro-1,2-dihidro-2-oxo-3h-ind ol-3-ilideno, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
KR20110020902A (ko) 2008-06-06 2011-03-03 베링거 인겔하임 인터내셔날 게엠베하 글루코코르티코이드 유사체, 이의 제조방법, 약제학적 조성물 및 이의 용도
JP5651110B2 (ja) 2008-07-29 2015-01-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規化合物
WO2013137371A1 (fr) * 2012-03-15 2013-09-19 興和株式会社 Nouveau composé pyrimidine et médicament comprenant celui-ci
CN103664737A (zh) * 2012-09-25 2014-03-26 杨子娇 一类治疗房角狭窄的化合物及其用途
CN111683976B (zh) 2018-02-05 2022-11-18 生物辐射实验室股份有限公司 具有阴离子交换-疏水混合模式配体的色谱树脂
CN114957084B (zh) * 2022-01-21 2023-05-09 九江学院 一种吲哚酮类化合物及其制备方法和应用
WO2025155711A1 (fr) * 2024-01-17 2025-07-24 The Board Of Trustees Of The Leland Stanford Junior University Inhibiteurs de lrrk2 et compositions et utilisations associées

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease

Also Published As

Publication number Publication date
ATE243195T1 (de) 2003-07-15
AU763361B2 (en) 2003-07-17
YU21301A (sh) 2003-04-30
NZ510845A (en) 2003-10-31
CA2342622A1 (fr) 2000-04-06
EE200100184A (et) 2002-08-15
ID27757A (id) 2001-04-26
JP2002525356A (ja) 2002-08-13
EA200100320A1 (ru) 2001-10-22
DK1115704T3 (da) 2003-09-29
BG105327A (bg) 2001-12-29
US20040058978A1 (en) 2004-03-25
US6855710B2 (en) 2005-02-15
AU6086399A (en) 2000-04-17
NO20011477L (no) 2001-03-22
HUP0104973A2 (hu) 2002-04-29
NO20011477D0 (no) 2001-03-22
BR9914065A (pt) 2001-06-19
HRP20010216A2 (en) 2002-04-30
WO2000018734A1 (fr) 2000-04-06
ES2196860T3 (es) 2003-12-16
PL346898A1 (en) 2002-03-11
EP1115704A1 (fr) 2001-07-18
PT1115704E (pt) 2003-11-28
EP1115704B1 (fr) 2003-06-18
SK4032001A3 (en) 2001-11-06
KR20010085841A (ko) 2001-09-07
HUP0104973A3 (en) 2002-06-28
TR200100854T2 (tr) 2001-12-21
DE59906030D1 (de) 2003-07-24
CN1319090A (zh) 2001-10-24
IL141622A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
SI1115704T1 (sl) Novi substituirani indolinoni z inhibitornim učinkom na različne kinaze in ciklin/CDK komplekse
DK1071665T3 (da) Substituerede indolinoner med en inhiberende virkning på kinaser og cyclin/CDK-komplekser
DE69909584D1 (de) Schraube mit Vertiefung und Schraubenziehereinsatz hierfür
DE69928608D1 (de) Fräse mit Randfräsmöglichkeit
HU9603142D0 (en) Integrated level two cache and memory controller with multiple data ports
NO20014659L (no) Arylsubstituerte pyrazoler, imidazoler, oksazoler, tiazoler og pyrroler samt deres anvendelse
PT1076558E (pt) 2-fenil-1-¬4-(2-aminoetoxi)-benzil|-indole em combinacao com estrogenios
DE69719348D1 (de) Fräser mit schneideinsatz
DE59801818D1 (de) Steckdübel
PT1157019E (pt) 4-alcenil (e alcinil) oxindolos como inibidores dequinases dependentes de ciclina em particular cdk2
DE69905364D1 (de) Fräsvorrichtung im bohrloch
NO304984B1 (no) Fosfonometylerte chitosaner samt deres anvendelse for bleking av cellulosematerialer og i kosmetiske sammensetninger
NO990053D0 (no) Fresstyring med orienterings- og dybdebestemmelsesevne
AU1815700A (en) Secure optically readable memory usable in connection with limited number of machines
SI1071665T1 (sl) Substituirani indolinoni, ki imajo inhibitorni učinek na kinaze in ciklin/CDK komplekse
FI964809A0 (fi) En utrustning foer tillverkning av taeckplaot
GB9809201D0 (en) Microcomputer chips with interconnected address and data paths
NO993998L (no) Verktøy nede i brønnen
IL134344A0 (en) Kinase activating dependent cyclin protein kinases, and their uses
FI973293A7 (fi) Sovitelma työkalussa
ITMI980292U1 (it) Oggetto reggi piatto e bicchiere per pasto in piedi
ITMI980880A1 (it) Oggetto reggi piatto e bicchiere per pasto in piedi
KR980000459U (ko) 좌우선회가능한 파지아암을 구비한 독서대
KR960000284U (ko) 싱크대의 미니선반
BR8802012A (pt) Plano integrado de preparacao de profissionais tecnicos nas areas contabil,juridica e administrativa de empresas em geral